
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Hyperfine Inc (HYPR)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: HYPR (2-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $1.19
1 Year Target Price $1.19
2 | Strong Buy |
0 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 72.75% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 112.87M USD | Price to earnings Ratio - | 1Y Target Price 1.19 |
Price to earnings Ratio - | 1Y Target Price 1.19 | ||
Volume (30-day avg) 4 | Beta 1.06 | 52 Weeks Range 0.53 - 1.90 | Updated Date 08/15/2025 |
52 Weeks Range 0.53 - 1.90 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.52 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-13 | When - | Estimate -0.12 | Actual -0.12 |
Profitability
Profit Margin - | Operating Margin (TTM) -510.15% |
Management Effectiveness
Return on Assets (TTM) -39.15% | Return on Equity (TTM) -67.86% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 87685781 | Price to Sales(TTM) 9.62 |
Enterprise Value 87685781 | Price to Sales(TTM) 9.62 | ||
Enterprise Value to Revenue 8.12 | Enterprise Value to EBITDA -0.72 | Shares Outstanding 62784600 | Shares Floating 58534789 |
Shares Outstanding 62784600 | Shares Floating 58534789 | ||
Percent Insiders 6.75 | Percent Institutions 14.56 |
Upturn AI SWOT
Hyperfine Inc
Company Overview
History and Background
Hyperfine, Inc., founded in 2014, is focused on reinventing magnetic resonance imaging (MRI) to make it more accessible. It developed the Swoop Portable MRI System, aiming to bring MRI technology to the point of care.
Core Business Areas
- MRI Systems: Development, manufacturing, and commercialization of portable MRI systems (Swoop) designed for point-of-care imaging.
- Services and Support: Providing service, maintenance, and support for installed MRI systems, including software updates and training.
Leadership and Structure
Hyperfine Inc. is led by a management team with experience in medical technology and imaging. The organizational structure includes departments for research and development, manufacturing, sales and marketing, and customer support.
Top Products and Market Share
Key Offerings
- Swoop Portable MRI System: Hyperfine's primary product, a portable MRI system designed for use at the point of care. This system has received FDA clearance and is being marketed to hospitals and medical facilities. Market share data is still developing as the company is relatively new. Key competitors include traditional MRI vendors like Siemens Healthineers (SIEGY), GE Healthcare (GE), and Philips (PHG), although Swoop targets a different segment of the market (portable, point-of-care MRI).
Market Dynamics
Industry Overview
The MRI market is a mature market. Hyperfine is working to address the unmet need of accessible imaging by reducing size, cost, and infrastructure requirements for MRI. Hyperfine is creating a new market by offering a lower-performance portable MRI option at a substantially lower price point.
Positioning
Hyperfine positions itself as an innovator in accessible MRI, targeting a niche market for point-of-care imaging. The company's competitive advantage lies in the portability, ease of use, and lower cost compared to traditional MRI systems.
Total Addressable Market (TAM)
Estimates for the global MRI market range from $5 billion to $7 billion, with point-of-care imaging representing a smaller, but growing, segment. Hyperfine is targeting this niche within the broader MRI market. How the new market develops will determine Hyperfine's TAM.
Upturn SWOT Analysis
Strengths
- Innovative portable MRI technology
- Lower cost compared to traditional MRI
- FDA clearance
- Addressing unmet needs in point-of-care imaging
Weaknesses
- Limited clinical data compared to established MRI systems
- Reliance on single product (Swoop)
- High operating losses
- Requires a new installation workflow
Opportunities
- Expansion into new clinical applications
- Partnerships with hospitals and medical facilities
- International market expansion
- Further development of AI-powered imaging capabilities
Threats
- Competition from established MRI vendors
- Technological advancements by competitors
- Regulatory hurdles
- Slow adoption of new technologies in healthcare
Competitors and Market Share
Key Competitors
- SIEG.DE
- GE
- PHG
Competitive Landscape
Hyperfine's competitive advantage lies in its portable MRI technology and lower cost. However, it faces challenges from established MRI vendors with broader product portfolios, larger installed bases, and more extensive clinical data.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been characterized by the initial commercialization of the Swoop system and the expansion of its installed base.
Future Projections: Future growth depends on continued adoption of the Swoop system, expansion into new markets, and the development of new products and services.
Recent Initiatives: Recent initiatives include expansion of sales and marketing efforts, partnerships with healthcare providers, and ongoing research and development to enhance the capabilities of the Swoop system.
Summary
Hyperfine is an innovative company aiming to disrupt the MRI market with its portable system. Its strengths lie in its unique technology and potential to improve accessibility. However, it faces challenges related to adoption, cash burn, and competition from larger players. Careful monitoring of its financial performance and market penetration is essential.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Press Releases
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Investment decisions should be made in consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hyperfine Inc
Exchange NASDAQ | Headquaters Guilford, CT, United States | ||
IPO Launch date 2021-01-27 | CEO, President & Director Ms. Maria Sainz | ||
Sector Healthcare | Industry Medical Devices | Full time employees 111 | Website https://hyperfine.io |
Full time employees 111 | Website https://hyperfine.io |
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, New Zealand, and internationally. The company was founded in 2014 and is based in Guilford, Connecticut.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.